<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>MicroRNAs (miRNAs) are small, non-coding <z:chebi fb="40" ids="33697">RNAs</z:chebi> that can function as oncogenes or <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressors in human <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Recent reports have highlighted the oncogenic aspects of microRNA miR-125b </plain></SENT>
<SENT sid="2" pm="."><plain>However, the clinical significance of miR-125b in <z:e sem="disease" ids="C0685938" disease_type="Neoplastic Process" abbrv="">gastrointestinal cancers</z:e> has not been sufficiently investigated </plain></SENT>
<SENT sid="3" pm="."><plain>To this end, we analyzed miR-125b expression in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> cases </plain></SENT>
<SENT sid="4" pm="."><plain>Quantitative RT-PCR was used to evaluate miR-125b expression in 89 colorectal <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cases to determine the clinicopathological significance of miR-125b expression </plain></SENT>
<SENT sid="5" pm="."><plain>The high miR-125b expression group showed a greater incidence of advanced <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> size and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> invasion compared to the low miR-125b expression group (P&lt;0.05) </plain></SENT>
<SENT sid="6" pm="."><plain>In addition, the high miR-125b expression group had a significantly poorer prognosis compared to the low expression group (P&lt;0.05) </plain></SENT>
<SENT sid="7" pm="."><plain>Multivariate analysis indicated that high miR-125b expression was an independent prognostic factor for survival </plain></SENT>
<SENT sid="8" pm="."><plain>Our analysis of miR-125b focused on the miR-125b/p53 pathway </plain></SENT>
<SENT sid="9" pm="."><plain>In vitro assays revealed that overexpression of miR-125b repressed the endogenous level of p53 protein in human <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> cells </plain></SENT>
<SENT sid="10" pm="."><plain>These data show that miR-125b is directly involved in <z:e sem="disease" ids="C0178874" disease_type="Neoplastic Process" abbrv="">cancer progression</z:e> and is associated with poor prognosis in human <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="11" pm="."><plain>Our findings suggest that miR-125b could be an important prognostic indicator for <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> patients </plain></SENT>
</text></document>